Consensus statement on the modern therapy of paget's disease of bone from a western osteoporosis alliance symposium
- 1 April 2001
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (4) , 620-626
- https://doi.org/10.1016/s0149-2918(01)80065-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- The Management of Paget's Disease of BoneNew England Journal of Medicine, 1997
- Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of boneArthritis & Rheumatism, 1995
- Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's diseaseJournal of Bone and Mineral Research, 1995
- Perspectives: A practical guide to the use of pamidronate in the treatment of Paget's diseaseJournal of Bone and Mineral Research, 1994
- Skeletal Distribution and Biochemical Parameters of Paget??s DiseaseClinical Orthopaedics and Related Research, 1987
- Orthopedic aspects of paget's disease of boneArthritis & Rheumatism, 1980
- Biochemical measurements in Paget's disease of boneEuropean Journal of Clinical Investigation, 1977
- Response of Paget's disease to porcine and salmon calcitonins: Effects of long-term treatmentThe American Journal of Medicine, 1974
- HUMAN CALCITONIN IN THE TREATMENT OF PAGET'S BONE DISEASEThe Lancet, 1971